Hangzhou Tigermed Consulting Co., Ltd Share Price

Equities

300347

CNE100001KV8

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 09/07/2025 5-day change 1st Jan Change
57.58 CNY +2.06% Intraday chart for Hangzhou Tigermed Consulting Co., Ltd +6.47% +5.42%

Valuation: Hangzhou Tigermed Consulting Co., Ltd

Capitalization 47.4B 6.6B 5.64B 5.26B 4.86B 9.05B 566B 10.11B 62.9B 23.93B 264B 24.76B 24.25B 967B P/E ratio 2025 *
45x
P/E ratio 2026 * 34.4x
Enterprise value 47.1B 6.56B 5.6B 5.22B 4.83B 8.99B 562B 10.05B 62.51B 23.78B 263B 24.61B 24.1B 961B EV / Sales 2025 *
6.63x
EV / Sales 2026 * 5.81x
Free-Float
72.37%
Yield 2025 *
0.52%
Yield 2026 * 0.65%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.06%
1 week+6.47%
Current month+7.99%
1 month+15.09%
3 months+25.31%
6 months+14.02%
Current year+5.42%
More quotes
1 week 52.7
Extreme 52.7
58.89
1 month 48.17
Extreme 48.17
58.89
Current year 41.61
Extreme 41.61
62.25
1 year 41.61
Extreme 41.61
82.79
3 years 36.12
Extreme 36.12
130
5 years 36.12
Extreme 36.12
209.41
10 years 14.2
Extreme 14.2
209.41
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 51 20/10/2022
President 57 31/12/2019
Director TitleAgeSince
Director/Board Member 56 31/12/2004
Chairman 62 -
Director/Board Member 65 -
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.06%+6.47%+17.51%-51.98% 6.44B
+1.26%+0.68%+11.49%-1.12% 49.23B
+4.32%+4.21%+76.16%+43.83% 28.96B
-1.33%-1.39%-23.79%-25.32% 28.45B
+0.34%+9.79%+4.85%+9.59% 28.26B
+0.03%-1.58%+27.86%-23.32% 12.53B
-0.59%-0.02%-53.46%-29.73% 12.05B
+0.17%-1.45%+16.33%-5.68% 10.36B
+5.03%+1.93%+29.31%+94.38% 10.18B
-0.46%-0.84%+70.09% - 10.13B
Average +1.08%+0.34%+17.64%+1.18% 19.66B
Weighted average by Cap. +1.08%+0.04%+16.42%+3.65%
See all sector performances

Financials

2025 *2026 *
Net sales 7.1B 989M 845M 787M 728M 1.36B 84.77B 1.51B 9.42B 3.59B 39.61B 3.71B 3.63B 145B 8.03B 1.12B 955M 890M 823M 1.53B 95.89B 1.71B 10.66B 4.05B 44.8B 4.2B 4.11B 164B
Net income 1.11B 155M 132M 123M 114M 212M 13.26B 237M 1.47B 561M 6.19B 580M 568M 22.66B 1.54B 214M 183M 170M 158M 293M 18.34B 328M 2.04B 776M 8.57B 803M 786M 31.36B
Net Debt -298M -41.53M -35.48M -33.06M -30.58M -56.91M -3.56B -63.62M -396M -151M -1.66B -156M -153M -6.09B -740M -103M -88.01M -82.02M -75.86M -141M -8.83B -158M -982M -374M -4.13B -386M -378M -15.1B
More financial data * Estimated data
Logo Hangzhou Tigermed Consulting Co., Ltd
Hangzhou Tigermed Consulting Co, Ltd. specialises in providing professional services to pharmaceutical and biotech companies. The group supports its clients in all processes of clinical development and product commercialization. Net sales break down by activity as follows: - provision of clinical trial services and related technological services (51.8%); - provision of clinical research consulting services (48.2%). China accounts for 46% of sales.
Employees
10,185
More about the company
Date Price Change Volume
08/07/25 57.58 ¥ +2.06% 17,837,990
08/07/25 56.42 ¥ +6.47% 19,641,070
07/07/25 52.99 ¥ -1.43% 5,953,595
04/07/25 53.76 ¥ -0.67% 8,535,043
03/07/25 54.12 ¥ +0.59% 9,059,009

End-of-day quote Shenzhen S.E., July 08, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
57.58CNY
Average target price
54.42CNY
Spread / Average Target
-5.49%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300347 Stock